Shinsuke Iida1, Morio Matsumoto2, Hiroshi Kosugi3, Hidehisa Noguchi4, Akiko Suzuki4, Hiroshi Yamazaki4, Hirohiko Shibayama5 (1.Hematol.&Oncol. Nagoya City University, Nagoya, Japan, 2.Hematol. National Hospital Org. Sibukawa Medical Center, Shibukawa, Japan, 3.Ogaki Municipal Hospital, Ogaki, Japan, 4.Janssen Pharmaceutical K.K. , Tokyo, Japan, 5.Osaka Univ. Grad. Schl. Med., Osaka, Japan)
Session information
Oral Session
Oral Session 3-10A MM: Clinical trials
Sun. Oct 14, 2018 8:30 AM - 9:30 AM No.10 (Osaka International Convention Center, 10F 1009)
Chair: Yasushi Takamatsu (Division of Medical Oncology, Hematology and Infections Diseases, Fukuoka University, Japan)
Morio Matsumoto1, Kazutaka Sunami2, Kenshi Suzuki3, Kazuteru Ohashi4, Shinsuke Iida5, Shinichiro Okamoto6, Hiroshi Handa7, Kosei Matsue8, Suresh Shelat9, Oumar Sy9, Masafumi Miyoshi10, Masafumi Taniwaki11 (1.National Hospital Organization Shibukawa Medical Center, Shibukawa, Japan, 2.National Hospital Organization Okayama Medical Center, Okayama, Japan, 3.Japanese Red Cross Medical Center, Tokyo, Japan, 4.Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Tokyo, 5.Nagoya City University Hospital, Nagoya, Japan, 6.Keio University Hospital, Tokyo, Japan, 7.Gunma University Hospital, Maebashi, Japan, 8.Kameda Medical Center, Kamogawa, Japan, 9.Bristol-Myers Squibb, Princeton, NJ, USA, 10.Bristol-Myers Squibb K.K., Tokyo, Japan, 11.University Hospital, Kyoto Prefectural University of Medicine, Kyoto, Japan)
Koji Nagafuji1, Takayuki Ishikawa2, Hiroyuki Takamatsu3, Kenshi Suzuki4, Jianping Wang5, Robin Carson6, Wendy Crist6, Ming Qi7, Tomoaki Fujisaki8 (1.Division of Hematology and Oncology, Department of Medicine, Kurume University School of Medicine, Kurume, Japan, 2.Department of Internal Medicine, Division of Immuno-Hematology, Kobe General Central Hospital, Kobe, Japan, 3.Hematology/Respiratory Medicine, Kanazawa University, Kanazawa, Japan, 4.Japanese Red Cross Medical Center, Department of Hematology, Tokyo, Japan, 5.Janssen Research & Development, LLC, Raritan, United States of America, 6.Janssen Biotech, Horsham, United States of America, 7.Janssen Research and Development, LLC, Spring House, United States of America, 8.Department of Internal Medicine, Matsuyama Red-Cross Hospital, Matsuyama, Japan)
Shinsuke Iida1, Dai Maruyama2, Gakuto Ogawa3, Shigeru Kusumoto1, Suguru Fukuhara2, Noriko Fukuhara4, Sachiko Seo5, Kana Miyazaki6, Makoto Yoshimitsu7, Junya Kuroda8, Norifumi Tsukamoto9, Hideki Tsujimura10, Akira Hangaishi11, Takahiro Yamauchi12, Takahiko Utsumi13, Ishikazu Mizuno14, Yasushi Takamatsu15, Yasuyuki Nagata16, Koichiro Minauchi17, Eiichi Ohtsuka18, Ichiro Hanamura19, Takashi Tokunaga20, Shinichiro Yoshida21, Satoshi Yamazaki22, Youko Suehiro23, Yutaro Kamiyama24, Kenichi Miyamoto3, Yuko Watanabe3, Kunihiro Tsukasaki5, Hirokazu Nagai20 (1.Hematol. & Oncol., Nagoya City Univ., Nagoya, Japan, 2.Hematol., National Cancer Center Hosp., Tokyo, Japan, 3.JCOG Data Center, National Cancer Center Hosp., Tokyo, Japan, 4.Hematol., & Rheumatol., Tohoku Univ. Hosp., Sendai, Japan, 5.Hematol., National Cancer Center Hosp. East, Kashiwa, Japan, 6.Hematol., & Oncol., Mie Univ., Tsu, Japan, 7.Hematol. & Immunol., Kagoshima Univ. Hosp., Kagoshima, Japan, 8.Div. Hematol. & Oncol., Kyoto Pref. Univ., Kyoto, Japan, 9.Hematol., Gunma Univ., Maebashi, Japan, 10.Hematol.-Oncol., Chiba Cancer Center, Chiba, Japan, 11.Hematol., NTT Med. Center Tokyo, Tokyo, Japan, 12.Hematol. & Oncol., Univ. of Fukui, Fukui, Japan, 13.Hematol. & Oncol., Shiga General Hosp., Moriyama, Japan, 14.Hematol., Hyogo Cancer Center, Akashi, Japan, 15.Med. Oncol., Hematol. & Infectious Dis., Fukuoka Univ., Fukuoka, Japan, 16.Int. Med. III, Hamamatsu Univ. Sch. of Med., Hamamatsu, Japan, 17.Hematol., Sapporo Hokuyu Hosp., Sapporo, Japan, 18.Hematol., Oita Pref. Hosp., Oita, Japan, 19.Hematol., Aichi Med. Univ., Nagakute, Japan, 20.Hematol., NHO Nagoya Med. Center, Nagoya, Japan, 21.Hematol., NHO Nagasaki Med. Center, Ohmura, Japan, 22.Hematol. & Clin. Res. Inst., NHO Kyushu Med. Center, Fukuoka, Japan, 23.Hematol., NHO Kyushu Cancer Center, Fukuoka, Japan, 24.Clin. Oncol. & Hematol., The Jikei Univ., Tokyo, Japan)
Kenshi Suzuki1, Morio Matsumoto2, Takaaki Cho3, Junya Kuroda4, Masafumi Taniwaki4, Kazutaka Sunami5, Hiroshi Kosugi6, Kiyoshi Ando7, Dai Maruyama8, Kensei Tobinai8, Shinsuke Iida9 (1.Japanese Red Cross Medical Center, Tokyo, Japan, 2.NHO Shibukawa Medical Center, Gunma, Japan, 3.Niigata Cancer Center Hospital, Niigata, Japan, 4.Kyoto Prefectural University of Medicine, Kyoto, Japan, 5.NHO Okayama Medical Center, 6.Ogaki Municipal Hospital, Gifu, Japan, 7.Tokai University Hospital, Kanagawa, Japan, 8.National Cancer Center Hospital, Tokyo, Japan, 9.Nagoya City University Hospital, Aichi, Japan)
Hiroshi Kosugi1, Naoki Takezako2, Morio Matsumoto3, Shinsuke Iida4, Takayuki Ishikawa5, Yukio Kondo6, Kiyoshi Ando7, Takaaki Cho8, Hirokazu Miki9, Itaru Matsumura10, Kazutaka Sunami11, Takanori Teshima12, Hiromi Iwasaki13, Yasushi Onishi14, Masahiro Kizaki15, Koji Izutsu16, Dai Maruyama16, Kensei Tobinai16, Kenshi Suzuki16 (1.Ogaki Municipal Hospital, Gifu, Japan, 2.NHO Disaster Medical Center, Tokyo, Japan, 3.NHO Shibukawa Medical Center, Gunma, Japan, 4.Nagoya City University Hospital, Aichi, Japan, 5.Kobe City Medical Center General Hospital, Hyogo, Japan, 6.Kanazawa University Hospital, Kanazawa, Japan, 7.Tokai University Hospital, Kanagawa, Japan, 8.Niigata Cancer Center Hospital, Niigata, Japan, 9.Tokushima University Hospital, Tokushima, Japan, 10.Kindai University Hospital, Osaka, Japan, 11.NHO Okayama Medical Center, 12.Hokkaido University Hospital, Hokkaido, Japan, 13.NHO Kyushu Medical Center, 14.Tohoku University Hospital, Miyagi, Japan, 15.Saitama Medical Center, Saitama Medical University, Saitama, Japan, 16.National Cancer Center Hospital, Tokyo, Japan, 17.Japanese Red Cross Medical Center, Tokyo, Japan)